Percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures: An evidence-based analysis

Ontario Health Technology Assessment Series

Volumn 10, Issue 19, 2010, Pages 1-45

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BONE CEMENT; NAPROXEN; OPIATE; POLY(METHYL METHACRYLATE);

ADVERSE OUTCOME; ANALGESIA; BACKACHE; BARTHEL INDEX; CLINICAL RESEARCH; CLINICAL TRIAL; COMPRESSION FRACTURE; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; DAILY LIFE ACTIVITY; DALLAS PAIN QUESTIONNAIRE; DRUG COST; DRUG USE; ECONOMIC EVALUATION; EUROPEAN QUALITY OF LIFE 5 DIMENSIONS; EVIDENCE BASED MEDICINE; FRAGILITY FRACTURE; FUNCTIONAL ASSESSMENT; HUMAN; KYPHOPLASTY; MENTAL FUNCTION; METHODOLOGY; MINI MENTAL STATE EXAMINATION; OUTCOMES RESEARCH; PAIN ASSESSMENT; PEER REVIEW; PERCUTANEOUS VERTEBROPLASTY; POSTOPERATIVE COMPLICATION; PULMONARY BONE CEMENT EMBOLISM; QUALITY OF LIFE; QUALITY OF LIFE QUESTIONNAIRE ON THE EUROPEAN FOUNDATION FOR OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; ROLAND MORRIS DISABILITY QUESTIONNAIRE; SAFETY; SHAM PROCEDURE; SHORT FORM 36; SOCIAL STATUS; VERTEBRA FRACTURE;

EID: 78149347705     PISSN: 19157398     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Cahoj PA, Cook JL, Robinson BS. Efficacy of percutaneous vertebral augmentation and use of physical therapy intervention following vertebral compression fractures in older adults: A systematic review. J Geriatr Phys Ther 2007; 30(1):31-40.
2. Hamady M, Sheard S. Role of cementoplasty in the management of compression vertebral body fractures. Postgrad Med J 2009; 85(1004):293-8.
3. Cotten A, Dewatre F, Cortet B, Assaker R, Leblond D, Duquesnoy B et al. Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Radiology 1996; 200(2):525-30. (Pubitemid 26249909)
4. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17(1):1-12.
5. Singh JA, Murphy S, Bhandari M. Assessment of the methodologic quality of medical and surgical clinical trials in patients with arthroplasty. J Rheumatol 2009; 36(12):2642-54.
6. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328(7454):1490.
7. Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009;361(6):569-79.
8. Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 2009; 361(6):557-68.
9. Rousing R, Andersen MO, Jespersen SM, Thomsen K, Lauritsen J. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three-months follow-up in a clinical randomized study. Spine 2009;34(13):1349-54.
10. Voormolen MH, Mali WP, Lohle PN, Fransen H, Lampmann LE, van-der GY et al. Percutaneous vertebroplasty compared with optimal pain medication treatment: short-term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. AJNR Am J Neuroradiol 2007; 28:555-60.
11. Liu JT, Liao WJ, Tan WC, Lee JK, Liu CH, Chen YH et al. Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study. Osteoporos Int 2010; 21(2):359-64.
12. Goodman C. Literature searching and evidence interpretation for assessing health care practices. Stockholm, Sweden: The Swedish Council on Technology Assessment in Health Care. 1993 81 p. SBU-Report No 119E.
13. Rousing R, Hansen KLM, Andersen MOM, Jespersen SMM, Thomsen KM, Lauritsen JMM. Twelve-months follow-up in forty-nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study. Spine 2010; 35(5):478-82.
14. Ostelo RW, Deyo RA, Stratford P, Waddell G, Croft P, Von KM et al. Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine 2008; 33(1):90-4.
15. Trout AT, Kallmes DF, Gray LA, Goodnature BA, Everson SL, Comstock BA et al. Evaluation of vertebroplasty with a validated outcome measure: the Roland-Morris Disability Questionnaire. AJNR Am J Neuroradiol 2005; 26(10):2652-7.
16. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005; 14(6):1523-32.
17. Copay AG, Glassman SD, Subach BR, Berven S, Schuler TC, Carreon LY. Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and pain scales. Spine J 2008; 8(6):968-74.
18. Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O et al. Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int 1999; 10(2):150-60.
19. Hawthorne G, Osborne R. Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure. Aust N Z J Public Health 2005; 29(2):136-42. (Pubitemid 40585235)
20. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA, III, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15(4):721-39.
21. Ontario Ministry of Health and Long-Term Care. Ontario schedule of benefits for physician services under the Health Insurance Act [Internet]. [updated 2010 Mar 24; cited 2010 Apr]. Available from: http://www.health.gov.on. ca/english/providers/program/ohip/sob/physserv/physserv-mn.html
22. Canadian Pharmacists Association. Compendium of pharmaceuticals and specialties. Ottawa, ON: The Association; 2009.
23. Ontario Ministry of Health and Long-Term Care. Ontario drug benefit formulary [Internet]. [updated 2009 Apr 13; cited 2010 May]. Available from: https://www.healthinfo.moh.gov.on.ca/formulary/index.jsp